Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon
Cochrane Database of Systematic Reviews · 06.11.2023 · 2025 (2)
DOI: 10.1002/14651858.cd014089 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cochrane Database of Systematic Reviews, online erschienen am 06.11.2023. Verfasst von Nancy Maltez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Ottawa Hospital, Ottawa, Canada. Hauptthemen laut MEDLINE: Phosphodiesterase 5 Inhibitors, Scleroderma, Systemic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The Ottawa Hospital, Ottawa, Canada.
- Cochrane Musculoskeletal, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
- Department of Medicine, University of Western Ontario, London, Canada.
- Bruyère Research Institute, University of Ottawa, Ottawa, Canada.
- Pediatric Critical Care Medicine, SUNY Upstate Medical University, Syracuse, USA.
- School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Zitieren
APA
Maltez, N., Maxwell, L. J., Rirash, F., Tanjong Ghogomu, E., Harding, S. E., Tingey, P. C., Wells, G. A., Tugwell, P., & Pope, J. (2023). Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon. Cochrane Database of Systematic Reviews, 2025(2). https://doi.org/10.1002/14651858.cd014089
Vancouver
Maltez N, Maxwell LJ, Rirash F, Tanjong Ghogomu E, Harding SE, Tingey PC, et al. Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon. Cochrane Database of Systematic Reviews. 2023;2025(2). doi:10.1002/14651858.cd014089
BibTeX
@article{Maltez2023,
author = {Maltez, Nancy and Maxwell, Lara J and Rirash, Fadumo and Tanjong Ghogomu, Elizabeth and Harding, Sarah E and Tingey, Paul C and Wells, George A and Tugwell, Peter and Pope, Janet},
title = {Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon},
journal = {Cochrane Database of Systematic Reviews},
year = {2023},
volume = {2025},
number = {2},
doi = {10.1002/14651858.cd014089}
}
EUVIMED